icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Sat 15 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

News

fh
icon 2025-07-29

SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia

The Saudi Food and Drug Authority (SFDA) has approved the registration of Leqembi (lecanemab) for the treatment of patients with mild cognitive...
More
d
icon 2025-07-23

SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder

The Saudi Food and Drug Authority (SFDA) has approved the registration of Skyclarys (Omaveloxolone), which was previously designated as an Orphan Drug...
More
d
icon 2025-07-20

SFDA Welcomes Submissions for the 5th Regulatory Research Day 2025

The Saudi Food and Drug Authority (SFDA) is pleased to announce that it is now accepting scientific submissions for the 5th Regulatory Research Day...
More
45674356
icon 2025-05-26

The SFDA Grants Breakthrough Designation to "Itovebi" for Advanced Hormone Resistant Breast Cancer Treatment

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to Itovebi (Inavolisib( developed by Roche. The investigational therapy...
More
45674356
icon 2025-05-22

The SFDA Grants Breakthrough Designation to “MIQNAF” for Acute Bacterial Infections Treatment

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to MIQNAF (Nafithromycin), developed by Wockhardt Bio AG. This...
More
The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”
icon 2025-05-05

The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to Eli Lilly’s medication, Imlunestrant (Inluriyo), for the treatment of...
More